VALDOSTA, Ga. – CVS, Walgreens, and Rite Aid are no longer selling Zantac or any of the related brands of heartburn medication after the FDA linked ranitidine medication with cancer.
Earlier this month the FDA learned that some ranitidine medications contain levels of nitrosodimethylamine (NDMA), which is a probable human carcinogen.
According to a report from CNN, while Zantac and other drugs are being removed from shelves, the drug has not been recalled and the FDA is not recommending that patients stop taking ranitidine at this time. However, customers who purchased the drug are able to return it to CVS for a refund.
CVS released in a statement on September 28, 2019:
CVS Pharmacy has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice. This action is being taken out of an abundance of caution due to a recent Product Alert from the U.S. Food and Drug Administration (FDA) that ranitidine products may contain a low level of nitrosodimethylamine (NDMA), which is a probable human carcinogen.CVS statement
Zantac, the brand-name version of the drug, is sold by Sanofi, but generic versions are widely sold.
The New York Times reported the drug maker Novartis said that its generic-drug division, Sandoz, had stopped distributing a prescription form of ranitidine worldwide while it investigates the F.D.A.’s findings. GlaxoSmithKline has also stopped shipping its generic version of the drug, as well as Dr. Reddy’s Laboratories, a major generic manufacturer.